Neurocrine Biosciences, Inc’s recently made public that its Director GORMAN KEVIN CHARLES unloaded Company’s shares for reported $1.16 million on May 27 ’25. In the deal valued at $120.38 per share,9,613 shares were sold. As a result of this transaction, GORMAN KEVIN CHARLES now holds 514,596 shares worth roughly $64.74 million.
Then, KEVIN CHARLES GORMAN bought 9,613 shares, generating $1,155,290 in total proceeds.
Before that, RASTETTER WILLIAM H sold 30,000 shares. Neurocrine Biosciences, Inc shares valued at $3,305,952 were divested by the Director at a price of $110.20 per share. As a result of the transaction, RASTETTER WILLIAM H now holds 37,491 shares, worth roughly $4.72 million.
Needham upgraded its Neurocrine Biosciences, Inc [NBIX] rating to a Buy from a a Hold in a research note published recently. A number of analysts have revised their coverage, including RBC Capital Mkts’s analysts, who increased its forecast for the stock in mid April from “a Sector perform” to “an Outperform”. Deutsche Bank began covering NBIX with “Hold” recommendation on February 11, 2025.
Price Performance Review of NBIX
On Monday, Neurocrine Biosciences, Inc [NASDAQ:NBIX] saw its stock fall -0.59%% to $125.8. Over the last five days, the stock has gained 1.13%. Neurocrine Biosciences, Inc shares have fallen nearly -3.87% since the year began. Nevertheless, the stocks have fallen -7.84% over the past one year. While a 52-week high of $157.98 was reached on 01/30/25, a 52-week low of $84.23 was recorded on 04/09/25.
Levels Of Support And Resistance For NBIX Stock
The 24-hour chart illustrates a support level at 124.58, which if violated will result in even more drops to 123.35. On the upside, there is a resistance level at 127.51. A further resistance level may holdings at 129.21.
How much short interest is there in Neurocrine Biosciences, Inc?
A steep rise in short interest was recorded in Neurocrine Biosciences, Inc stocks on 2025-05-30, dropping by -0.42 million shares to a total of 4.06 million shares. Yahoo Finance data shows the prior-month short interest on 2025-04-30 was 4.49 million shares. There was a decline of -10.35%, which implies that there is a negative sentiment for the stock.
